In Brief
![](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3-300x300.jpg)
![](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3-300x300.jpg)
Drugs & Targets
In The Clinic
Latest Issue
NEWS ALERTS
Conversations with The Cancer Letter
Contributors
Bulletin editorial team, American College of Surgeons
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- “This is our time, and the time is now”—Chapman tells us about Jefferson’s final push for Comprehensive designation
- Leading a Comprehensive Cancer Center—one job or two?
- Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week - Rathmell: To improve funding outlook, we must reverse distrust in science
Recent Issues
The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.